Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026

Go back to Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026
(NASDAQ: XERS) Delayed: 7.20 +0.30 (4.35%)
Previous Close $6.90    52 Week High
Open $6.90    52 Week Low
Day High $7.30    P/E N/A 
Day Low $6.86    EPS
Volume 1,978,616